Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Jul 31;16(7):e65842.
doi: 10.7759/cureus.65842. eCollection 2024 Jul.

Eosinophilic Dermatosis of Hematologic Malignancy

Affiliations
Case Reports

Eosinophilic Dermatosis of Hematologic Malignancy

Gabriella Beharry et al. Cureus. .

Abstract

Eosinophilic dermatosis of hematologic malignancy (EDHM) is a rare chronic skin condition commonly affecting individuals with underlying hematologic malignancies, most notably chronic lymphocytic leukemia (CLL). EDHM presents as pruritic, insect-like bites, but without patient-reported contact/bites of insects. We present a case of a 44-year-old male who presented to Elkhorn Dermatology with a scaly rash and serpiginous borders on the nasal tip and right cutaneous upper lip. The patient was diagnosed with CLL one year prior and had been on zanubrutinib for 10 days since presenting to the dermatology clinic. Initial treatment with antifungal and antibiotic therapies showed no improvement, leading to a punch biopsy that revealed perivascular and periadnexal lymphocytic dermatitis with eosinophils. This finding, along with the patient's underlying CLL, led to a diagnosis of EDHM. This case highlights the diagnostic challenges and therapeutic complexities associated with EDHM in patients with hematologic malignancies.

Keywords: dermatologic manifestations; dermatological manifestation of malignancy; eosinophilic dermatosis; eosinophilic dermatosis of hematological malignancy; hematologic malignancies; medical dermatology.

PubMed Disclaimer

Conflict of interest statement

Human subjects: Consent was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Figures

Figure 1
Figure 1. (a) and (b) Scaly patches with a serpiginous border located on the nasal tip. (c) and (d) Erythematous papules and nodules on the bilateral cheeks and temples.
Figure 2
Figure 2. H&E ×1.5 and ×25 demonstrating a nodular infiltrate, composed of mature lymphocytes, histiocytes, plasma cells, and numerous eosinophils extending into the deep dermis.
H&E: hematoxylin and eosin stain.

References

    1. Eosinophilic dermatosis of hematologic malignancy: a case report. Almeida FT, Caldas R, Rodrigues AP, Ferreira O, Brito C. Dermatol Online J. 2020;26:1–3. - PubMed
    1. Eosinophilic dermatosis of hematologic malignancy mimicking varicella zoster infection: report in a woman with chronic lymphocytic leukemia and review of the literature. Bari O, Cohen PR. Dermatol Pract Concept. 2017;7:6–15. - PMC - PubMed
    1. Insect bite-like reaction in patients with hematologic malignant neoplasms. Barzilai A, Shpiro D, Goldberg I, et al. Arch Dermatol. 1999;135:1503–1507. - PubMed
    1. Eosinophilic dermatosis of myeloproliferative disease: characterization of a unique eruption in patients with hematologic disorders. Byrd JA, Scherschun L, Chaffins ML, et al. https://jamanetwork.com/journals/jamadermatology/article-abstract/478521. Arch Dermatol. 2001;137:1378–1380. - PubMed
    1. Eosinophilic dermatosis of hematologic malignancy. Farber MJ, La Forgia S, Sahu J, Lee JB. J Cutan Pathol. 2012;39:690–695. - PubMed

Publication types

LinkOut - more resources